YouTube31 Dec 2025
3m

BMO's Evan Seigerman: More clarity out of the FDA could drive smaller biotech names in 2026

Podcast cover

CNBC Television

Open in Podwise to generate AI notes

Sign in to process this episode and unlock summaries, transcripts, highlights and translations.

Open in Podwise

Shownotes are not generated by Podwise.

BMO's Evan Seigerman: More clarity out of the FDA could drive smaller biotech names in 2026